104504 VO Production of Recombinant Proteins for Research and Medical Applications
winter semester 2021/2022 | Last update: 20.07.2021 | Place course on memo listDr. Pidder Jansen-Dürr Dr. Pidder Jansen-Dürr, +43 512 507 50844
assoz. Prof. Dr. Robin Alicia Kimmel, PhD assoz. Prof. Dr. Robin Alicia Kimmel, PhD, +43 512 507 51408
Adjunct Professor Priv.-Doz. Dr. Jerome Mertens Adjunct Professor Priv.-Doz. Dr. Jerome Mertens, +43 512 507 51413
ao. Univ.-Prof. Dr. Thorsten Schwerte ao. Univ.-Prof. Dr. Thorsten Schwerte, +43 512 507 51862
Univ.-Prof. Dr. Birgit Weinberger Univ.-Prof. Dr. Birgit Weinberger, +43 512 507 50845
Univ.-Prof. Dr. Martin Widschwendter Univ.-Prof. Dr. Martin Widschwendter
Univ.-Prof. Dr. Werner Zwerschke Univ.-Prof. Dr. Werner Zwerschke, +43 512 507 50832
Students who have attended this lecture should be able to choose an appropriate expression system for a particular application and should be independently capable to generate corresponding expression constructs.
Knowledge of important prokaryotic-, eukaryotic- and in vitro- expression systems that are appropriate for the production of recombinant proteins. Techniques for the generation of expression constructs and methods/principles for the purification of recombinant proteins. Use of recombinant proteins in industrial, medical or scientific applications.
Blocked lecture with visual support and interactive teaching.
Written multiple-choice test at the end of the blocked lecture. If required, further exams possible.
Relevant chapters/textbooks will be announced during the lecture. Handouts related to important topics are available during and after the lecture under the web link below.
This course is offered as a joint lecture together with 104708 VO Disease Mechanisms and Therapeutical Approaches.
Date and time for the exam(s) will be arranged with the interested participants during the lecture. Please apply for the exam via email to the lecturer with your name and your matriculation number at least 3 days before the exam. For further information and short-term changes please visit the web link below.